Recent changes

Jump to: navigation, search

Track the most recent changes to the wiki on this page.

Recent changes options
Legend:
N
This edit created a new page (also see list of new pages)
m
This is a minor edit
b
This edit was performed by a bot
(±123)
The page size changed by this number of bytes
Show last 50 | 100 | 250 | 500 changes in last 1 | 3 | 7 | 14 | 30 days
Hide registered users | Hide anonymous users | Hide my edits | Show bots | Hide minor edits
Show new changes starting from 12:57, 2 December 2020
   

2 December 2020

     12:51  (User creation log). . [Lukedliu‎; Drmnaveed123‎]
      12:51 . . User account Drmnaveed123 (talk | contribs) was created ‎
      09:21 . . User account Lukedliu (talk | contribs) was created ‎

1 December 2020

 m   20:58  Pralsetinib (Gavreto)‎ (diff | hist) . . (+492). . Jwarner (talk | contribs)
 m   20:54  Cisplatin (Platinol)‎ (diff | hist) . . (+1,059). . Jwarner (talk | contribs) (History of changes in FDA indication)
 m   16:48  Acute myeloid leukemia‎ (diff | hist) . . (+885). . Jwarner (talk | contribs) (Decitabine & Venetoclax {{#subobject:30c499|Regimen=1}})

30 November 2020

 m   11:42  Chlorambucil (Leukeran)‎ (diff | hist) . . (+368). . Jwarner (talk | contribs) (History of changes in FDA indication)
 m   11:39  Carmustine wafer, polifeprosan 20 (Gliadel)‎ (diff | hist) . . (+138). . Jwarner (talk | contribs)
 m   11:36  Carmustine (BCNU)‎ (diff | hist) . . (+1,093). . Jwarner (talk | contribs)
 m   11:30  Busulfan (Myleran)‎ (diff | hist) . . (+193). . Jwarner (talk | contribs) (History of changes in FDA indication)
     07:56 (User creation log) . . User account Rsneha (talk | contribs) was created ‎

29 November 2020

 m   22:00  Bleomycin (Blenoxane)‎ (diff | hist) . . (+687). . Jwarner (talk | contribs) (History of changes in FDA indication)
 m   21:52  Asparaginase (Elspar)‎ (diff | hist) . . (+774). . Jwarner (talk | contribs) (Also known as)
 m   21:48  Aminoglutethimide (Cytadren)‎ (diff | hist) . . (+30). . Jwarner (talk | contribs) (History of changes in FDA indication)
 m   21:46  Vinblastine (Velban)‎ (diff | hist) . . (+72). . Jwarner (talk | contribs) (Also known as)
 m   21:43  Lomustine (CCNU)‎ (diff | hist) . . (+894). . Jwarner (talk | contribs) (Also known as)
 m   21:37  Vincristine (Oncovin)‎ (diff | hist) . . (+110). . Jwarner (talk | contribs)
 m   21:30  Ponatinib (Iclusig)‎ (diff | hist) . . (+289). . Jwarner (talk | contribs) (History of changes in FDA indication)
 m   21:28  Pemetrexed (Alimta)‎ (diff | hist) . . (-7). . Jwarner (talk | contribs)
 m   21:22  Osimertinib (Tagrisso)‎ (diff | hist) . . (+31). . Jwarner (talk | contribs) (History of changes in FDA indication)
N    21:20  Contexts‎‎ (6 changes | history) . . (+475). . [Jwarner‎ (6×)]
 m    21:20 (cur | prev) . . (+21). . Jwarner (talk | contribs) (Untreated)
 m    21:18 (cur | prev) . . (+29). . Jwarner (talk | contribs) (FDA indication language)
 m    21:17 (cur | prev) . . (+40). . Jwarner (talk | contribs) (Treatment contexts)
 m    21:09 (cur | prev) . . (+22). . Jwarner (talk | contribs) (FDA indication language)
 m    20:23 (cur | prev) . . (+98). . Jwarner (talk | contribs) (Treatment contexts)
N     20:22 (cur | prev) . . (+265). . Jwarner (talk | contribs) (Created page with "''The purpose of this page is to define treatment contexts used in the HemOnc ontology; it is not for other purposes at this time.'' =FDA indication language= ==Metastatic==...")
 m   21:19  Nilotinib (Tasigna)‎ (diff | hist) . . (+115). . Jwarner (talk | contribs) (History of changes in FDA indication)
 m   21:18  Neratinib (Nerlynx)‎ (diff | hist) . . (+4). . Jwarner (talk | contribs) (History of changes in FDA indication)
 m   21:16  Mercaptopurine (6-MP)‎ (diff | hist) . . (-123). . Jwarner (talk | contribs) (History of changes in FDA indication)
 m   21:12  Letrozole (Femara)‎ (diff | hist) . . (+55). . Jwarner (talk | contribs) (History of changes in FDA indication)
 m   21:08  Ixabepilone (Ixempra)‎ (diff | hist) . . (+2). . Jwarner (talk | contribs) (History of changes in FDA indication)
 m   21:07  Irinotecan (Camptosar)‎ (diff | hist) . . (-26). . Jwarner (talk | contribs) (History of changes in FDA indication)
 m   20:56  Imatinib (Gleevec)‎‎ (2 changes | history) . . (+41). . [Jwarner‎ (2×)]
 m    20:56 (cur | prev) . . (+35). . Jwarner (talk | contribs) (Hypereosinophilic syndrome (HES))
 m    20:12 (cur | prev) . . (+6). . Jwarner (talk | contribs) (History of changes in FDA indication)
 m   20:54  Idelalisib (Zydelig)‎ (diff | hist) . . (+328). . Jwarner (talk | contribs) (History of changes in FDA indication)
 m   20:50  Dasatinib (Sprycel)‎ (diff | hist) . . (+164). . Jwarner (talk | contribs) (History of changes in FDA indication)
 m   20:26  Biomarkers‎‎ (8 changes | history) . . (+643). . [Jwarner‎ (8×)]
 m    20:26 (cur | prev) . . (+25). . Jwarner (talk | contribs)
 m    20:13 (cur | prev) . . (+48). . Jwarner (talk | contribs)
 m    20:05 (cur | prev) . . (+34). . Jwarner (talk | contribs)
 m    20:02 (cur | prev) . . (+6). . Jwarner (talk | contribs)
 m    19:59 (cur | prev) . . (+176). . Jwarner (talk | contribs) (Genes)
 m    19:59 (cur | prev) . . (+189). . Jwarner (talk | contribs) (Proteins)
 m    19:57 (cur | prev) . . (+71). . Jwarner (talk | contribs) (Genes)
 m    19:53 (cur | prev) . . (+94). . Jwarner (talk | contribs) (Genes)
 m   20:25  Ramucirumab (Cyramza)‎ (diff | hist) . . (+29). . Jwarner (talk | contribs) (History of changes in FDA indication)
 m   20:21  Regimen classes‎ (diff | hist) . . (-2). . Jwarner (talk | contribs)
 m   20:17  Panitumumab (Vectibix)‎ (diff | hist) . . (+157). . Jwarner (talk | contribs) (History of changes in FDA indication)
 m   20:08  Gemtuzumab ozogamicin (Mylotarg)‎‎ (2 changes | history) . . (+22). . [Jwarner‎ (2×)]
 m    20:08 (cur | prev) . . (-2). . Jwarner (talk | contribs) (History of changes in FDA indication)
 m    20:08 (cur | prev) . . (+24). . Jwarner (talk | contribs) (History of changes in FDA indication)
 m   20:06  Cetuximab (Erbitux)‎‎ (2 changes | history) . . (+69). . [Jwarner‎ (2×)]
 m    20:06 (cur | prev) . . (+32). . Jwarner (talk | contribs) (History of changes in FDA indication)
 m    20:04 (cur | prev) . . (+37). . Jwarner (talk | contribs) (History of changes in FDA indication)